Medical Implants

Medical Implants Market Outlook

The global medical implants market is poised for significant growth, with an estimated value of USD 150 billion in 2023 and projected to reach USD 250 billion by 2035, representing a compound annual growth rate (CAGR) of 6.5%. The rise in the aging population, increasing prevalence of chronic diseases, and advancements in technology are primary factors driving market expansion. Furthermore, the growing demand for minimally invasive surgical procedures and improved healthcare infrastructure are expected to enhance market growth. The emergence of smart implants and the integration of Internet of Things (IoT) in medical devices also play a pivotal role in enhancing patient outcomes and generating new opportunities for market players. The global focus on enhancing healthcare outcomes through innovative implant solutions solidifies the medical implants market as a crucial segment in the healthcare industry.

Growth Factor of the Market

Several factors are contributing to the growth of the medical implants market. Firstly, the increasing prevalence of chronic diseases, such as diabetes, cardiovascular diseases, and orthopedic disorders, necessitates the use of various medical implants to improve patient quality of life. Additionally, advancements in technology, including the development of bioresorbable implants and 3D printing techniques, are revolutionizing the manufacturing of medical implants, making them safer and more efficient. Furthermore, the rise in the geriatric population is leading to a higher demand for surgical procedures, subsequently increasing the need for various implants. The growing emphasis on preventive healthcare and the rising number of road accidents are also driving the demand for orthopedic and dental implants. Lastly, favorable reimbursement policies and increasing investments in healthcare infrastructure are expected to positively influence market growth in the coming years.

Key Highlights of the Market

• The medical implants market is anticipated to grow at a CAGR of 6.5% from 2023 to 2035.
• Increasing demand for minimally invasive surgical procedures is driving market growth.
• The emergence of smart implants integrated with IoT technology is expected to enhance patient monitoring.
• Geographically, North America holds the largest share of the market due to advanced healthcare facilities.
• The orthopedic implants segment is projected to lead the market, driven by rising incidence rates of orthopedic diseases.

By Product Type

Orthopedic Implants:

Orthopedic implants are designed to support damaged bones and joints, significantly contributing to the growth of the medical implants market. These implants include devices such as plates, screws, joints, and prosthetics that are used in a variety of orthopedic surgeries like hip replacements, knee replacements, and fracture repairs. The growing incidence of orthopedic disorders due to lifestyle changes, obesity, and sports injuries is escalating the demand for orthopedic procedures, thereby increasing the market for orthopedic implants. Furthermore, advancements in material science and technology are leading to the development of biocompatible materials that minimize rejection rates and enhance healing outcomes, thereby driving this segment's growth.

Dental Implants:

Dental implants have emerged as a popular solution for individuals with missing teeth, serving both functional and aesthetic purposes. This segment has witnessed rapid growth due to a rise in dental issues stemming from poor oral hygiene, aging populations, and the increasing preference for cosmetic dentistry. Dental implants provide a strong foundation for fixed or removable replacement teeth, offering better comfort and functionality compared to traditional dentures. The technological advancements in implant materials and techniques, such as immediate load implants and computer-guided surgery, have further fueled their adoption, establishing dental implants as a significant segment within the medical implants market.

Cardiovascular Implants:

Cardiovascular implants include devices such as stents, heart valves, and pacemakers, which play a crucial role in managing heart diseases and improving cardiovascular health. With the rising prevalence of cardiovascular diseases driven by factors like sedentary lifestyles, unhealthy diets, and an aging population, the demand for cardiovascular implants is on the rise. Furthermore, advancements in minimally invasive surgical techniques and the development of bioengineered devices are enhancing procedure outcomes, thereby fostering growth in this segment. The ongoing research into innovative materials and designs for cardiovascular implants is expected to drive further advancements and increase patient acceptance of these devices.

Ophthalmic Implants:

Ophthalmic implants are specifically designed for the treatment of various eye conditions, including cataracts, glaucoma, and retinal diseases. The market for ophthalmic implants is growing due to the increasing prevalence of eye disorders, alongside an aging population that is more susceptible to vision-related issues. Innovations in implant technology, such as the introduction of intraocular lenses and retinal implants, are improving surgical outcomes and patient satisfaction. Additionally, the rise in awareness about eye health and advancements in surgical techniques are expected to contribute positively to the growth of this segment within the medical implants market.

Neurostimulators:

Neurostimulators are medical devices used to deliver electrical stimulation to specific nerves in the body to alleviate pain or restore function. They are increasingly used in the treatment of chronic pain, epilepsy, Parkinson's disease, and other neurological disorders. The growing recognition of the effectiveness of neurostimulation therapy, combined with advancements in technology that allow for more precise stimulation and patient-controlled devices, is propelling the demand for neurostimulators. Additionally, the increasing incidence of neurological disorders and the advancement of healthcare infrastructure that supports neuromodulation therapies are expected to drive the growth of this segment significantly.

By Application

Orthopedic:

The orthopedic application of medical implants is one of the largest segments in the market, driven by the increasing incidence of orthopedic conditions such as arthritis, osteoporosis, and sports injuries. The demand for orthopedic implants is fueled by the rising number of orthopedic surgeries performed, which is attributable to the aging population and increasing physical activity levels among younger demographics. Moreover, innovations in surgical techniques and implant materials are leading to better patient outcomes, further enhancing the adoption of orthopedic implants. As healthcare providers focus on improving patients' quality of life through effective treatment options, the orthopedic segment is expected to maintain robust growth in the coming years.

Dental:

In the dental application segment, the demand for implants is surging due to the increasing prevalence of dental caries and periodontal diseases along with the growing desire for aesthetic enhancements. Dental implants are considered the gold standard for replacing missing teeth and providing structural support to dental prostheses. The technological advancements in dental implantology, including the development of implant designs that ensure better osseointegration and reduced healing times, have contributed to the segment's growth. Additionally, the rise of dental tourism and the integration of advanced imaging technologies in dental procedures are expected to further stimulate the growth of dental implants in both developed and emerging markets.

Cardiovascular:

The cardiovascular application segment has witnessed tremendous growth due to the increasing prevalence of cardiovascular diseases, which remain a leading cause of mortality worldwide. Cardiovascular implants, such as stents and heart valves, play a vital role in managing these conditions, leading to significant advancements in treatment options and improved patient outcomes. The increase in awareness about heart health, along with the growth of preventive healthcare practices, is driving the demand for cardiovascular interventions. Innovative product developments, such as biodegradable stents and transcatheter heart valves, are expected to enhance the effectiveness and longevity of cardiovascular implants, thereby bolstering this segment's growth.

Ophthalmology:

Ophthalmology is an emerging application segment for medical implants, with a significant rise in the use of intraocular lenses, retinal implants, and glaucoma drainage devices. The increasing prevalence of eye disorders, particularly among the aging population, is propelling the demand for ophthalmic surgeries and corresponding implants. Advances in ophthalmic surgical techniques and the introduction of more effective implant materials are enhancing the safety and effectiveness of these procedures. As patients increasingly seek solutions for vision-related problems, the ophthalmic application segment is expected to grow at a healthy rate in the foreseeable future.

Neurology:

The neurology application segment of the medical implants market is expanding due to the rising incidence of neurological disorders, such as epilepsy and chronic pain conditions. Neurostimulators and implantable devices used in neuromodulation are gaining traction as effective treatment options for managing these conditions. The growing acceptance of neuromodulation therapies and increasing investments in research and development of innovative neurostimulator technologies are driving growth in this segment. Moreover, the enhanced focus on personalized medicine and targeted therapies in neurology is expected to create new opportunities for advanced neuromodulation devices, further propelling market expansion.

By Distribution Channel

Hospitals:

Hospitals remain the primary distribution channel for medical implants, accounting for a significant share of the market. The high volume of surgical procedures conducted within hospital settings, along with the availability of skilled surgeons and advanced medical technology, drives the demand for implants. Hospitals often have established relationships with implant manufacturers and suppliers, ensuring timely access to a wide range of products. The growing investment in healthcare infrastructure and the rising number of surgical procedures performed in hospitals are expected to enhance the market for medical implants through this distribution channel.

Specialty Clinics:

Specialty clinics are becoming increasingly important in the distribution of medical implants, particularly for specific procedures like orthopedic, dental, and ophthalmic surgeries. These clinics often provide focused care and specialized services, catering to patients seeking specific treatments. The rise in outpatient surgeries and the growing preference for specialized care have contributed to the growth of this distribution channel. Additionally, as patients become more informed and seek personalized treatment options, specialty clinics are positioned to meet these demands effectively, further expanding their share of the medical implants market.

Online Stores:

The trend of purchasing medical implants online is gaining momentum, driven by the increasing adoption of e-commerce in the healthcare sector. Online stores provide convenience and accessibility for healthcare professionals and patients, allowing them to compare products and prices easily. The COVID-19 pandemic has accelerated the shift toward online purchasing, with many suppliers enhancing their digital presence to reach a broader audience. While the online medical implant market is still emerging, it represents a significant opportunity for growth as more consumers and healthcare providers embrace digital solutions for purchasing medical products.

Retail Pharmacies:

Retail pharmacies play a vital role in the distribution of certain types of medical implants, especially those that are used for outpatient procedures or post-operative care, such as orthopedic supports and dental products. The convenience offered by retail pharmacies allows patients to access necessary implants quickly and easily, contributing to patient satisfaction. As consumers increasingly seek one-stop solutions for their healthcare needs, retail pharmacies are adapting their inventory to include a broader range of medical implant products. This trend is expected to strengthen the role of retail pharmacies in the medical implants market over time.

Direct Sales:

Direct sales are a crucial distribution channel for medical implant manufacturers, allowing them to maintain close relationships with healthcare providers and ensure that their products meet specific clinical requirements. By engaging directly with hospitals and clinics, manufacturers can provide tailored solutions, training, and support for their products. This channel is particularly important for introducing new technologies and educating healthcare professionals about the benefits and applications of innovative implants. The direct sales model is anticipated to gain traction as manufacturers seek to enhance customer loyalty and establish long-term partnerships with healthcare providers.

By Material Type

Metallic:

Metallic materials are commonly used in medical implants due to their strength, durability, and biocompatibility. Titanium and stainless steel are the most widely employed metals in orthopedic and dental implants, offering excellent mechanical properties and resistance to corrosion. The use of advanced metallic alloys is enhancing implant performance, allowing for more complex designs and improved integration with bone tissues. The growing demand for long-lasting and reliable implants is expected to drive the metallic material segment further, as manufacturers continue to innovate and develop new metallic solutions tailored for specific medical applications.

Ceramic:

Ceramic materials have gained popularity in the medical implants market due to their excellent biocompatibility, aesthetic appeal, and wear resistance. Bioceramics are increasingly used in applications such as dental implants and orthopedic implants, where they promote bone growth and reduce the risk of rejection. The ability to customize ceramic materials for specific applications enhances their adoption in various surgical procedures. As research continues to advance the properties and applications of ceramic materials in medical implants, this segment is expected to witness significant growth in the coming years.

Polymeric:

Polymeric materials are increasingly being utilized in medical implants due to their flexibility, lightweight nature, and potential for biodegradability. These materials are commonly used in applications such as soft tissue implants, drug delivery systems, and scaffolds for tissue engineering. The development of advanced polymeric materials that mimic the properties of natural tissues is driving innovation in the medical implants market. Moreover, the rise in demand for minimally invasive surgical procedures is expected to further propel the adoption of polymeric implants as they offer enhanced flexibility and ease of handling during surgeries.

Natural:

Natural materials, including biological and biocompatible substances, are emerging as a unique segment in the medical implants market. Innovations in tissue engineering have led to the development of implants derived from natural sources, such as collagen and hyaluronic acid, which are used in applications such as skin grafts and cartilage repair. The growing focus on regenerative medicine and the use of natural materials that promote healing and tissue integration are expected to drive the growth of this segment. As research continues to explore the potential applications of natural materials in implants, this segment is poised for further expansion in the medical implants market.

By Region

North America dominates the medical implants market, accounting for approximately 35% of the total market share in 2023. The region's strong healthcare infrastructure, coupled with high healthcare expenditure and advanced technology adoption, significantly contributes to its leading position. The increasing prevalence of chronic diseases and orthopedic disorders, along with a growing geriatric population, further drives the demand for medical implants. Furthermore, the presence of established key players and continuous innovations in implant technologies are expected to bolster market growth in North America at a CAGR of around 5.8% over the forecast period.

Europe holds the second-largest share of the medical implants market, estimated at around 30% in 2023. The region benefits from a robust healthcare system, high levels of healthcare spending, and a growing focus on research and development. The increasing incidence of dental and orthopedic procedures, along with advancements in implant materials and technologies, is anticipated to drive market growth in Europe. Additionally, the rising awareness about the benefits of innovative medical implants and the aging population are expected to further enhance the market trajectory in this region. Meanwhile, the Asia Pacific region is emerging as a significant market with an expected CAGR of 7% due to improving healthcare access and infrastructure.

Opportunities

The medical implants market is brimming with opportunities driven by factors such as technological advancements and an increasing focus on personalized medicine. Innovations in implant technology, including the development of smart implants that can monitor conditions in real time and release therapeutic agents, are transforming the landscape of medical implants. As healthcare providers prioritize patient-centered care, the demand for customizable and patient-specific implants is rising, leading to new market entrants and collaborations between technology companies and healthcare providers. Furthermore, the growing emphasis on preventive healthcare and the rise of telemedicine are creating avenues for the development of innovative implant solutions, further enhancing market opportunities.

In addition, the increasing prevalence of chronic diseases and the growing geriatric population are creating a substantial opportunity for market players to introduce innovative medical implants tailored to specific healthcare needs. The expansion of healthcare infrastructure in emerging markets presents a significant opportunity for manufacturers to tap into previously underserved patient populations. Moreover, as regulatory pathways for approvals become more streamlined, manufacturers can expedite the introduction of new products into the market, amplifying their reach. Investment in research and development is crucial as it drives innovation and helps companies stay competitive in this rapidly evolving landscape, ultimately leading to better patient outcomes and increased market share.

Threats

The medical implants market faces several threats, primarily related to stringent regulatory requirements and the increasing prevalence of product recalls. Regulatory agencies have established rigorous guidelines for the approval and monitoring of medical implants, which can prolong the time it takes for new products to reach the market. This lengthy approval process may hinder the ability of companies to innovate and adapt to changing market demands. Additionally, product recalls due to safety concerns or adverse effects can damage a company's reputation and diminish consumer trust, impacting sales and market share. As competition intensifies among manufacturers, maintaining compliance with regulations while ensuring product safety and efficacy is paramount to minimizing these threats.

Moreover, the rising cost of healthcare and the growing emphasis on cost containment in many regions pose significant challenges for medical implant manufacturers. As healthcare providers strive to reduce expenses, there is an increasing demand for cost-effective implant solutions that do not compromise quality. This push for affordability may compel manufacturers to sacrifice profit margins, leading to increased competition and pricing pressures. Furthermore, the presence of counterfeit medical implants in the market poses a significant threat to patient safety and trust in genuine products. Companies must prioritize quality assurance and establish robust supply chain measures to combat these threats effectively.

Competitor Outlook

• Medtronic
• Johnson & Johnson
• Stryker Corporation
• Baxter International Inc.
• Zimmer Biomet
• Boston Scientific Corporation
• Smith & Nephew
• Abbott Laboratories
• NuVasive Inc.
• Implant Direct
• Coloplast A/S
• Hernia Repair Solutions
• DePuy Synthes
• Invuity
• Simbionix USA Corporation

The overall competitive landscape of the medical implants market is characterized by the presence of several key players who are actively engaged in research and development activities to innovate and improve their product offerings. Major companies like Medtronic and Johnson & Johnson are at the forefront of technological advancements, focusing on creating implants that provide better patient outcomes and integrate seamlessly with existing healthcare systems. These companies invest heavily in R&D to explore new materials and designs that can enhance the effectiveness and safety of medical implants, which is crucial for maintaining their competitive edge in a rapidly evolving market. Furthermore, strategic collaborations and partnerships among industry players are becoming increasingly common as they seek to enhance their market presence and leverage each other's strengths.

Companies like Stryker Corporation and Zimmer Biomet are also major players in the orthopedic implants segment, continuously innovating to meet the rising demand for joint replacement and fixation devices. Their focus on expanding product portfolios and enhancing distribution channels allows them to cater to a broader range of customers, further solidifying their market positions. Additionally, firms such as Boston Scientific and Abbott Laboratories are prominent in cardiovascular implants, investing in advanced technologies that improve the performance of their stents and heart valves. These companies are constantly evaluating new market trends and investing in the latest technologies to ensure they remain competitive in a rapidly changing landscape.

Furthermore, as the medical implants market continues to expand, emerging players are also entering the industry, bringing new and innovative solutions to the forefront. Companies like NuVasive and Implant Direct focus on niche segments within the market, targeting specific patient needs and enhancing product offerings through cutting-edge technology. As competition intensifies, it is essential for all players in the market to remain agile and responsive to changing healthcare demands and patient preferences. This competitive environment fosters innovation, ultimately benefiting healthcare providers and patients alike as they gain access to a wider range of high-quality medical implants designed to meet their specific requirements.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Invuity
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Medtronic
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Coloplast A/S
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 DePuy Synthes
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 NuVasive Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Zimmer Biomet
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Implant Direct
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Smith & Nephew
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Johnson & Johnson
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Abbott Laboratories
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Stryker Corporation
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Hernia Repair Solutions
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Baxter International Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Simbionix USA Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Boston Scientific Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Medical Implants Market, By Application
    • 6.1.1 Orthopedic
    • 6.1.2 Dental
    • 6.1.3 Cardiovascular
    • 6.1.4 Ophthalmology
    • 6.1.5 Neurology
  • 6.2 Medical Implants Market, By Product Type
    • 6.2.1 Orthopedic Implants
    • 6.2.2 Dental Implants
    • 6.2.3 Cardiovascular Implants
    • 6.2.4 Ophthalmic Implants
    • 6.2.5 Neurostimulators
  • 6.3 Medical Implants Market, By Material Type
    • 6.3.1 Metallic
    • 6.3.2 Ceramic
    • 6.3.3 Polymeric
    • 6.3.4 Natural
  • 6.4 Medical Implants Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Specialty Clinics
    • 6.4.3 Online Stores
    • 6.4.4 Retail Pharmacies
    • 6.4.5 Direct Sales

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Medical Implants Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Medical Implants market is categorized based on

By Product Type

• Orthopedic Implants
• Dental Implants
• Cardiovascular Implants
• Ophthalmic Implants
• Neurostimulators

By Application

• Orthopedic
• Dental
• Cardiovascular
• Ophthalmology
• Neurology

By Distribution Channel

• Hospitals
• Specialty Clinics
• Online Stores
• Retail Pharmacies
• Direct Sales

By Material Type

• Metallic
• Ceramic
• Polymeric
• Natural

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Medtronic
• Johnson & Johnson
• Stryker Corporation
• Baxter International Inc.
• Zimmer Biomet
• Boston Scientific Corporation
• Smith & Nephew
• Abbott Laboratories
• NuVasive Inc.
• Implant Direct
• Coloplast A/S
• Hernia Repair Solutions
• DePuy Synthes
• Invuity
• Simbionix USA Corporation